How CD38 Is Studied in NAD+ Metabolism

How CD38 Is Studied in NAD+ Metabolism

CD38 is studied in NAD+ metabolism as a multifunctional enzyme that can consume NAD+ and generate ADP-ribose-related products, including small amounts of cyclic ADP-ribose under defined conditions. Researchers examine CD38 through purified-enzyme assays, cell models, genetic knockout systems, inhibitor studies, metabolite measurements, calcium-related signaling assays, tissue-expression studies, and comparisons of NAD+ turnover. These experiments investigate biochemical mechanisms and should not be interpreted as evidence of longevity, tissue repair, disease modification, or human outcomes.

CD38 represents one of the major NAD+-consuming enzyme systems considered within NAD+ Research. Its activity must be distinguished from NAD+/NADH redox cycling, sirtuin activity, and PARP-dependent ADP-ribosylation because these processes use NAD+ through different biochemical mechanisms.

This article is provided for general educational purposes and explains biochemical, cellular, and research concepts associated with NAD+ research. It does not establish the regulatory status of any specific InStrips product or determine whether a particular product is appropriate for any person.

A difference in CD38 abundance, NADase activity, NAD+ concentration, ADP-ribose production, cyclic ADP-ribose measurement, or calcium-associated signaling is a biochemical research result. It does not establish a longevity, repair, or human functional outcome.

What Is CD38?

CD38 is a multifunctional protein with enzymatic and cell-surface-associated properties.

It has been studied as:

  • an NAD+ glycohydrolase
  • an ADP-ribosyl cyclase
  • a cyclic ADP-ribose hydrolase
  • a cell-surface protein
  • a regulator of selected NAD+-related signaling pathways

These activities are related but should not be treated as identical.

CD38 Uses NAD+ as a Substrate

One major CD38 reaction involves cleavage of NAD+.

The reaction can generate:

  • nicotinamide
  • ADP-ribose
  • smaller amounts of cyclic ADP-ribose under selected conditions

The relative amount of each product depends on enzyme conditions, substrates, pH, and experimental context.

NADase Activity

NADase activity refers to enzymatic cleavage of NAD+.

Researchers may measure:

  • loss of NAD+
  • formation of nicotinamide
  • formation of ADP-ribose
  • reaction velocity
  • substrate concentration dependence

A decrease in NAD+ in a CD38-containing system can support NADase activity when suitable controls exclude other NAD+-consuming reactions.

ADP-Ribosyl Cyclase Activity

CD38 can also catalyze formation of cyclic ADP-ribose from NAD+.

Researchers may examine:

  • cADPR production
  • reaction kinetics
  • substrate specificity
  • effects of mutations
  • effects of inhibitors

This cyclase reaction represents only a fraction of CD38-mediated NAD+ metabolism under many experimental conditions.

Cyclic ADP-Ribose

Cyclic ADP-ribose, or cADPR, is studied as an intracellular signaling molecule associated with calcium mobilization.

Research may measure:

  • cADPR concentration
  • changes after CD38 activation
  • calcium release
  • downstream calcium-sensitive pathways

A difference in cADPR concentration does not establish a complete physiological outcome.

CD38 Can Also Degrade cADPR

CD38 has been studied not only for generating cADPR but also for hydrolyzing it to ADP-ribose.

This means that CD38 can contribute to both:

  • formation of a signaling metabolite
  • removal of that signaling metabolite

Measured cADPR levels therefore reflect production and degradation rather than production alone.

CD38 and NAD+ Turnover

Because CD38 can consume substantial amounts of NAD+, researchers investigate its contribution to NAD+ turnover.

Experimental questions may include:

  • How rapidly does CD38 consume NAD+?
  • Which cells express the enzyme?
  • How does expression affect cellular NAD+?
  • What happens when CD38 is genetically removed?
  • How does inhibitor exposure change NAD+ measurements?

These questions address cellular metabolism rather than organism-level outcomes.

CD38 Expression

CD38 expression can vary among cell types and tissues.

Researchers may examine expression in:

  • immune cells
  • endothelial cells
  • metabolic tissues
  • brain-related cell populations
  • other experimentally selected tissues

High expression in one cell population does not establish that the same expression pattern exists in another tissue.

Messenger RNA and Protein Are Different Measurements

CD38 messenger RNA may be quantified through gene-expression methods.

CD38 protein may be measured using:

  • immunoblotting
  • flow cytometry
  • immunohistochemistry
  • mass spectrometry

An increase in messenger RNA does not necessarily produce an equivalent increase in active enzyme.

Flow Cytometry

Because CD38 can be expressed at the cell surface, flow cytometry is frequently used to measure CD38-positive cell populations.

Researchers may quantify:

  • percentage of CD38-positive cells
  • relative fluorescence intensity
  • co-expression with other cell markers
  • changes after stimulation

Surface expression does not directly quantify total cellular NADase activity.

Enzymatic Activity Must Be Measured Separately

A cell may contain CD38 protein without displaying the same catalytic activity under every condition.

Activity can be influenced by:

  • substrate availability
  • protein conformation
  • cellular location
  • pH
  • interacting molecules
  • post-translational regulation

Expression and enzyme activity should therefore remain separate endpoints.

Purified CD38 Assays

Purified-enzyme systems allow researchers to study CD38 chemistry without most other cellular reactions.

These assays may examine:

  • NAD+ cleavage
  • cADPR generation
  • ADP-ribose generation
  • substrate affinity
  • reaction velocity
  • inhibitor effects

The simplified system is useful for catalytic analysis but does not reproduce membrane orientation or cellular compartmentalization.

Fluorescent Substrate Assays

Some CD38 assays use synthetic NAD+-related substrates that become fluorescent after enzymatic conversion.

These assays can provide:

  • high-throughput activity measurements
  • concentration-response curves
  • inhibitor screening
  • kinetic measurements

Synthetic substrates may not behave exactly like NAD+, so findings can require confirmation using native metabolites.

Direct NAD+ Measurements

Researchers may measure NAD+ before and after manipulating CD38.

Methods may include:

  • liquid chromatography
  • mass spectrometry
  • enzymatic cycling assays
  • genetically encoded sensors

Total cellular NAD+ does not identify which compartment or enzyme pathway caused the change.

ADP-Ribose Measurements

ADP-ribose is a major product of CD38-mediated NAD+ hydrolysis.

Its concentration may be affected by:

  • CD38 activity
  • PARP-related pathways
  • other ADP-ribose metabolism
  • metabolite degradation

ADP-ribose should therefore not be treated as a uniquely CD38-specific marker without suitable controls.

CD38 Knockout Models

Genetic knockout models remove functional CD38 expression.

Researchers may compare knockout and control cells or animals for:

  • NAD+ concentration
  • NADase activity
  • cADPR-related measurements
  • calcium-associated signals
  • metabolic endpoints

Knockout findings can support the contribution of CD38 but may also include long-term compensatory changes.

Conditional Knockout Models

A conditional knockout can remove CD38 in a selected cell type or tissue rather than throughout the organism.

This can help distinguish contributions from:

  • immune cells
  • specific organs
  • selected cell lineages

Cell-specific knockout studies can reduce some interpretive problems associated with whole-body gene deletion.

CD38 Overexpression

Researchers may experimentally increase CD38 expression.

Measurements may include:

  • NAD+ concentration
  • NADase activity
  • ADP-ribose production
  • cADPR-related measurements
  • calcium signals

Artificial overexpression can produce enzyme levels outside the normal range for that cell type.

CD38 Inhibitors

Small molecules and antibody-based tools can be used experimentally to reduce CD38 activity.

Researchers may examine whether inhibition changes:

  • NAD+ consumption
  • NAD+ concentration
  • cADPR production
  • calcium-associated measurements
  • other downstream markers

An inhibitor should be evaluated for selectivity before a measured effect is attributed specifically to CD38.

Catalytic Inhibition and Protein Removal Are Different

Blocking the catalytic site of CD38 is different from eliminating the protein completely.

CD38 may have:

  • enzymatic functions
  • protein-interaction functions
  • cell-surface-associated roles

Differences between knockout and inhibitor studies can help distinguish these mechanisms.

Membrane Orientation Creates a Research Question

CD38 is commonly described as a membrane-associated protein whose catalytic domain can face the extracellular environment.

This creates a biochemical question because major cellular NAD+ pools are intracellular.

Research has therefore examined:

  • membrane orientation
  • intracellular CD38 pools
  • NAD+ transport or access
  • endosomal and organelle-associated CD38

The relationship between CD38 location and substrate access remains important for interpreting enzyme activity.

Extracellular NAD+ Metabolism

CD38 can metabolize NAD+-related material outside cells or at the cell surface.

Researchers may study:

  • extracellular NAD+
  • cell-surface NADase activity
  • extracellular ADP-ribose
  • related nucleotide metabolism

Extracellular measurements should not automatically be treated as equivalent to intracellular NAD+ metabolism.

Intracellular CD38

Research has also identified CD38 within intracellular membrane systems.

This allows investigation of:

  • organelle-associated NAD+ metabolism
  • local cADPR formation
  • calcium-associated signaling
  • intracellular NAD+ consumption

Cellular localization must therefore be measured rather than inferred solely from the protein’s traditional surface-marker classification.

CD38 and Calcium Signaling

CD38-related metabolites are studied in relation to intracellular calcium signaling.

Experimental endpoints may include:

  • cytosolic calcium concentration
  • calcium release from intracellular stores
  • calcium oscillations
  • calcium-sensitive enzyme activity

A calcium signal is a cellular signaling measurement and does not establish a whole-organism functional outcome.

Calcium Imaging

Fluorescent indicators can measure changes in cellular calcium over time.

Researchers may examine:

  • signal amplitude
  • signal duration
  • oscillation frequency
  • responses to CD38 manipulation

Indicator loading, calibration, cell type, and experimental conditions can affect interpretation.

cADPR and Calcium Must Be Linked Experimentally

An increase in cADPR and an increase in calcium occurring in the same experiment do not automatically establish direct causation.

Researchers may use:

  • cADPR antagonists
  • CD38 knockout systems
  • calcium-channel manipulation
  • time-course measurements

These experiments can help determine whether cADPR contributes to the measured calcium response.

NAADP Research

CD38 has also been investigated in relation to formation of nicotinic acid adenine dinucleotide phosphate, or NAADP, under selected conditions.

However, the contribution of CD38 to physiological NAADP generation can vary among systems and remains a separate research question.

Researchers should distinguish:

  • biochemical capability
  • cellular contribution
  • other possible generating enzymes

Cell-Type-Specific CD38 Research

CD38 can have different expression levels and signaling contexts in different cell populations.

Researchers may compare:

  • macrophages
  • lymphocytes
  • endothelial cells
  • metabolic tissues
  • other cell types

A high contribution to NAD+ turnover in one population does not establish the same contribution elsewhere.

Immune-Cell Research

CD38 was originally characterized in immune-cell contexts and remains widely used as a cellular marker.

Research may examine relationships among:

  • cell activation
  • CD38 expression
  • NADase activity
  • NAD+ concentration
  • cytokine-related signals

Expression as an immune marker and catalytic NADase activity are overlapping but distinct research concepts.

Inflammatory Signals Can Alter CD38 Expression

Some experimental inflammatory signals increase CD38 expression in selected cells.

Researchers may examine:

  • messenger RNA
  • surface protein
  • NADase activity
  • NAD+ concentration
  • time after stimulation

An induced change in one cultured cell population should not be extrapolated automatically to whole tissues.

CD38 and NAD+ Biosynthesis

NAD+ concentration reflects both synthesis and consumption.

Researchers may therefore measure CD38 together with enzymes involved in:

  • nicotinamide salvage
  • nicotinamide-riboside metabolism
  • other NAD+-producing pathways

An increase in NAD+ after CD38 inhibition may depend partly on the cell’s ability to continue synthesizing NAD+.

CD38 and Sirtuin Measurements

Because CD38 and sirtuins both interact with the cellular NAD+ environment, researchers sometimes compare their pathways.

Potential measurements include:

  • CD38 activity
  • NAD+ concentration
  • sirtuin-associated protein modifications
  • metabolic markers

A relationship between CD38 activity and a sirtuin-associated endpoint should be measured rather than assumed from shared NAD+ dependence.

CD38 and PARP Measurements

PARPs and CD38 can both consume NAD+ but use it for different reactions.

Researchers may distinguish:

  • CD38-mediated hydrolysis
  • PARP-mediated ADP-ribosylation
  • relative NAD+ consumption
  • cellular compartment

Changing total NAD+ does not reveal which consuming pathway was responsible.

NAD+ Flux Can Be More Informative Than a Single Concentration

A steady NAD+ concentration can be maintained even when both synthesis and consumption are high.

Researchers may therefore study NAD+ flux through:

  • isotope tracing
  • precursor labeling
  • time-resolved metabolite analysis
  • enzyme activity measurements

A single NAD+ concentration cannot describe the complete rate of NAD+ turnover.

Time Course Matters

CD38 expression and activity may change at different rates.

Researchers may collect data over:

  • minutes
  • hours
  • days
  • longer experimental periods

An early change in enzyme activity may precede a later change in protein abundance or NAD+ concentration.

Published Overview of CD38 Biochemistry

A review available through the National Library of Medicine describes CD38 as a multifunctional NAD+-metabolizing enzyme with NADase, ADP-ribosyl cyclase, and related catalytic activities. The review also discusses experimental evidence linking CD38 activity with cellular NAD+ homeostasis.

These findings support studying CD38 as a defined NAD+-consuming enzyme system rather than treating CD38 measurements as direct evidence of broader organism-level outcomes.

CD38 Research Connects With DNA-Damage Pathways Indirectly

CD38 and PARPs can both influence cellular NAD+ availability, but DNA-damage signaling involves additional enzymes and processes.

The distinct role of NAD+ within these pathways is examined in How NAD+ Is Studied in DNA-Damage Response Pathways.

What CD38 Research May Establish

A well-controlled study may establish that under its experimental conditions:

  • CD38 consumes NAD+
  • ADP-ribose formation changes
  • cADPR measurements change
  • CD38 deletion changes NAD+ concentration
  • an inhibitor changes NADase activity
  • CD38 manipulation changes selected calcium-related measurements

What CD38 Research Does Not Establish

These findings do not independently establish:

  • longevity
  • tissue repair
  • human functional outcomes
  • effects of an untested NAD+ intervention
  • equivalent results across all tissues
  • equivalent results across all NAD+-dependent enzymes
  • performance of a finished product

Final Perspective

CD38 research examines how a multifunctional enzyme contributes to NAD+ hydrolysis, ADP-ribose formation, cyclic ADP-ribose metabolism, calcium-related signaling, and cellular NAD+ turnover.

Expression, catalytic activity, NAD+ concentration, cADPR production, and calcium measurements are connected but distinct endpoints.

Accurate interpretation should identify the cell type, CD38 location, NAD+ pool, assay substrate, reaction product, genetic or chemical manipulation, and observation time while keeping CD38 biochemistry separate from longevity, repair, or human-outcome claims.

Back to blog